Drug makers face another $65 billion patent cliff
December 10, 2014 at 12:41 PM EST
Drug makers face another $65 billion patent cliff through the end of 2019, a research firm says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.